1. Home
  2. NXPLW vs MIST Comparison

NXPLW vs MIST Comparison

Compare NXPLW & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • MIST
  • Stock Information
  • Founded
  • NXPLW N/A
  • MIST 2003
  • Country
  • NXPLW United States
  • MIST Canada
  • Employees
  • NXPLW 166
  • MIST N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPLW Telecommunications
  • MIST Health Care
  • Exchange
  • NXPLW Nasdaq
  • MIST Nasdaq
  • Market Cap
  • NXPLW N/A
  • MIST N/A
  • IPO Year
  • NXPLW N/A
  • MIST N/A
  • Fundamental
  • Price
  • NXPLW N/A
  • MIST $0.89
  • Analyst Decision
  • NXPLW
  • MIST Strong Buy
  • Analyst Count
  • NXPLW 0
  • MIST 2
  • Target Price
  • NXPLW N/A
  • MIST $9.50
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • MIST 4.3M
  • Earning Date
  • NXPLW 03-31-2025
  • MIST 05-12-2025
  • Dividend Yield
  • NXPLW N/A
  • MIST N/A
  • EPS Growth
  • NXPLW N/A
  • MIST N/A
  • EPS
  • NXPLW N/A
  • MIST N/A
  • Revenue
  • NXPLW $66,482,000.00
  • MIST N/A
  • Revenue This Year
  • NXPLW N/A
  • MIST N/A
  • Revenue Next Year
  • NXPLW N/A
  • MIST N/A
  • P/E Ratio
  • NXPLW N/A
  • MIST N/A
  • Revenue Growth
  • NXPLW 179.89
  • MIST N/A
  • 52 Week Low
  • NXPLW $0.25
  • MIST $0.63
  • 52 Week High
  • NXPLW $0.26
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • MIST 38.49
  • Support Level
  • NXPLW N/A
  • MIST $0.77
  • Resistance Level
  • NXPLW N/A
  • MIST $0.88
  • Average True Range (ATR)
  • NXPLW 0.00
  • MIST 0.08
  • MACD
  • NXPLW 0.00
  • MIST 0.02
  • Stochastic Oscillator
  • NXPLW 0.00
  • MIST 83.28

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: